ACT Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.78M | Sell |
120,400
-106,200
| -47% | -$1.57M | 2.46% | 12 |
|
|
2022
Q2 | $3.57M | Sell |
226,600
-26,700
| -11% | -$420K | 4.99% | 6 |
|
|
2022
Q1 | $6.83M | Sell |
253,300
-226,100
| -47% | -$6.1M | 7.23% | 3 |
|
|
2021
Q4 | $17.7M | Buy |
479,400
+24,100
| +5% | +$892K | 12.83% | 2 |
|
|
2021
Q3 | $21.8M | Hold |
455,300
| – | – | 11.27% | 2 |
|
|
2021
Q2 | $15.4M | Buy |
+455,300
| New | +$15.4M | 7.92% | 3 |
|